NYSE - Delayed Quote • USD
Alcon Inc. (ALC)
At close: May 17 at 4:00 PM EDT
After hours: May 17 at 4:50 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 15 | 15 | 23 | 22 |
| Avg. Estimate | 0.73 | 0.75 | 3.07 | 3.5 |
| Low Estimate | 0.69 | 0.72 | 2.95 | 3.31 |
| High Estimate | 0.79 | 0.87 | 3.43 | 3.94 |
| Year Ago EPS | 0.69 | 0.66 | 2.74 | 3.07 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 12 | 12 | 22 | 21 |
| Avg. Estimate | 2.52B | 2.47B | 9.96B | 10.61B |
| Low Estimate | 2.5B | 2.44B | 9.81B | 10.36B |
| High Estimate | 2.55B | 2.49B | 10.06B | 10.9B |
| Year Ago Sales | 2.36B | 2.3B | 9.37B | 9.96B |
| Sales Growth (year/est) | 6.70% | 7.30% | 6.30% | 6.60% |
Earnings History
| CURRENCY IN USD | 6/30/2023 | 9/30/2023 | 12/31/2023 | 3/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.63 | 0.67 | 0.68 | 0.73 |
| EPS Actual | 0.69 | 0.66 | 0.69 | 0.78 |
| Difference | 0.06 | -0.01 | 0.01 | 0.05 |
| Surprise % | 9.50% | -1.50% | 1.50% | 6.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.73 | 0.75 | 3.07 | 3.5 |
| 7 Days Ago | 0.75 | 0.75 | 3.06 | 3.49 |
| 30 Days Ago | 0.75 | 0.76 | 3.06 | 3.49 |
| 60 Days Ago | 0.74 | 0.77 | 3.07 | 3.48 |
| 90 Days Ago | 0.77 | 0.73 | 3.01 | 3.44 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Jun 2024) | Next Qtr. (Sep 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 11 | 9 |
| Up Last 30 Days | 2 | 2 | 12 | 9 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | 9 | 9 | 2 | 4 |
Growth Estimates
| CURRENCY IN USD | ALC | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 5.80% | -- | -- | 8.00% |
| Next Qtr. | 13.60% | -- | -- | 12.40% |
| Current Year | 12.00% | -- | -- | 5.60% |
| Next Year | 14.00% | -- | -- | 13.00% |
| Next 5 Years (per annum) | 15.91% | -- | -- | 11.14% |
| Past 5 Years (per annum) | 10.11% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 5/15/2024 |
| Upgrade | Oppenheimer: Perform to Outperform | 5/15/2024 |
| Maintains | Mizuho: Buy to Buy | 5/15/2024 |
| Maintains | Baird: Outperform to Outperform | 5/15/2024 |
| Reiterates | Stifel: Buy to Buy | 5/15/2024 |
| Maintains | Needham: Buy to Buy | 5/15/2024 |
Related Tickers
COO The Cooper Companies, Inc.
97.31
-0.60%
BLCO Bausch + Lomb Corporation
14.65
-3.87%
RMD ResMed Inc.
218.57
-0.64%
WST West Pharmaceutical Services, Inc.
355.64
+0.43%
BDX Becton, Dickinson and Company
236.30
-0.14%
STVN Stevanato Group S.p.A.
20.71
-0.96%
BAX Baxter International Inc.
35.25
+0.23%
STAA STAAR Surgical Company
42.70
+0.19%
HOLX Hologic, Inc.
75.02
+0.09%
BLFS BioLife Solutions, Inc.
21.96
-0.05%